C.Q. Pharmaceutical Holding Co., Ltd.

000950

CNE0000010K0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
5.71 ^CNY	-0.35%		-4.03%	+14.89%

05-23	C.Q. Pharmaceutical Signs Cooperation Deal With JD.com; JD.com Drops 4%	MT
05-06	China Grants Drug Registration Certificate to C.Q. Pharmaceutical's Anti-Inflammatory Drug	MT

C.Q. Pharmaceutical Holding Co., Ltd. Announces Management Appointment

December 24, 2019 at 02:32 pm

C.Q. Pharmaceutical Holding Co., Ltd. announced the Election of Cheng Fei as a non-independent director and election of Lv Xiaoqing as a non-independent director.

Latest news about C.Q. Pharmaceutical Holding Co., Ltd.

C.Q. Pharmaceutical Signs Cooperation Deal With JD.com; JD.com Drops 4%	05-23	MT
China Grants Drug Registration Certificate to C.Q. Pharmaceutical's Anti-Inflammatory Drug	05-06	MT
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
C.Q. Pharma's Unit Gets Nod to Market Pregabalin Capsules	03-12	MT
C.Q. Pharmaceutical Considers Potential Change in Actual Controller; Shares Jump 8%	02-06	MT
C.Q. Pharmaceutical Holding Co., Ltd. Announces Executive Appointments	12-01	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
C.Q. Pharmaceutical Unit Buys Land-Use Rights in Chongqing For 51 Million Yuan	17/08/23	MT
C.Q. Pharmaceutical Withdraws Registration Application for Prasugrel Hydrochloride Tablets	21/07/23	MT
C.Q. Pharma Registers Hypertension Drug in China	06/07/23	MT
C.Q. Pharmaceutical Holding Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023	05/07/23	CI
C.Q. Pharmaceutical Holding Co., Ltd. Approves Cash Dividend for 2022	19/05/23	CI
C.Q. Pharmaceutical Holding Co., Ltd. Proposes Final Cash Dividend for 2022	27/04/23	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
C.Q. Pharmaceutical Unit Issues 300 Million Yuan Ultra-Short-Term Loan	23/02/23	MT
Fosun Pharma Signs Supply and Lease Agreements With Subsidiary	23/12/22	MT
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
C.Q. Pharmaceutical Holding Co., Ltd. Announces Implementation of 2021 Final Profit Distribution Plan, Payable on 28 June 2022	20/06/22	CI
C.Q. Pharmaceutical Holding Co., Ltd. Announces Cash Dividend for 2021	23/05/22	CI
C.Q. Pharmaceutical Holding Co., Ltd. Proposes Dividend for 2021	05/05/22	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Chongqing Pharmaceutical Co., Ltd. announced that it has received CNY 400.000004 million in funding from C.Q. Pharmaceutical Holding Co., Ltd.	06/01/22	CI

Chart C.Q. Pharmaceutical Holding Co., Ltd.

Duration

Period

Chart C.Q. Pharmaceutical Holding Co., Ltd.

More charts

C.Q. Pharmaceutical Holding Co., Ltd., formerly CHONGQING JIANFENG CHEMICAL CO., LTD, is a China-based company principally engaged in the wholesale and retail business of pharmaceuticals and medical devices. The Companyâs products include chemical drugs, biopharmaceuticals, Chinese traditional patent medicines, Chinese herbal medicines, medical devices, health products and cosmetics.

Sector

Pharmaceuticals

Calendar

19/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for C.Q. Pharmaceutical Holding Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.71

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
C.Q. PHARMACEUTICAL HOLDING CO., LTD.	+14.89%	1.36B
CARDINAL HEALTH, INC.	-4.38%	23.48B
SINOPHARM GROUP CO. LTD.	+4.16%	8.51B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+9.26%	8.42B
HUADONG MEDICINE CO., LTD	-24.53%	7.56B
H. LUNDBECK A/S	+13.31%	5.22B
EBOS GROUP LIMITED	0.00%	4.2B
GALENICA AG	-1.31%	3.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+6.13%	3.91B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.14%	3.61B

Pharmaceuticals Wholesale